Skip to main content

Foghorn Therapeutics Inc.

FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822462

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Foghorn Therapeutics Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of FHTX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders8893+5
Shares40.9M41.9M+974.5K (+2.4%)
Value$200.0M$226.1M+$26.1M (+13.1%)

New holders (15)

Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to FHTX in Q4 2025
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc607,670$3.28M0.00%
Qube Research & Technologies Ltd53,257$287.6K0.00%
Marshall Wace, LLP28,893$156.0K0.00%
Jump Financial, LLC24,129$130.3K0.00%
Two Sigma Investments, LP16,600$89.6K0.00%
XTX Topco Ltd15,662$84.6K0.00%
Algert Global LLC13,928$75.2K0.00%
Canada Pension Plan Investment Board12,800$69.1K0.00%
Invesco Ltd.10,785$58.2K0.00%
Brevan Howard Capital Management LP10,486$56.6K0.00%
Two Sigma Advisers, LP10,400$56.2K0.00%
Acadian Asset Management LLC7,726$41.0K0.00%
Brummer Multi-Strategy AB4,708$25.4K0.15%
UBS Asset Management Americas Inc374$2.02K0.00%
National Bank of Canada200$1.08K0.00%

Sold out (10)

Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of FHTX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Alphabet Inc.500,901$2.45M
Readystate Asset Management LP161,140$788.0K
Trexquant Investment LP22,025$107.7K
ProShare Advisors LLC15,228$74.5K
Occudo Quantitative Strategies LP11,873$58.1K
Alta Wealth Advisors LLC10,032$49.1K
SRS Capital Advisors, Inc.519$2.54K
Group One Trading, L.P.451$2.21K
Essential Partners LLC5$24
Colony Group, LLC1,549–